AIM Vaccine Announces 2023 Annual Results
Three Highly Anticipated Flagship Upgraded Vaccines Filing for Market Listing; Significant Breakthrough Achieved in the International Market HONG KONG SAR - Media OutReach Newswire - 28 March 2024 - AIM Vaccine Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce the results for the year ended 31 December 2023 (the "Period"). As of December 31, 2023, AIM Va...
read full article
